Related references
Note: Only part of the references are listed.ImmunoPET of CD38 with a radiolabeled nanobody: promising for clinical translation
Sixiang Shi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Response Prediction and Evaluation Using PET in Patients with Solid Tumors Treated with Immunotherapy
Frank J. Borm et al.
CANCERS (2021)
Imaging biomarkers for evaluating tumor response: RECIST and beyond
Ching-Chung Ko et al.
BIOMARKER RESEARCH (2021)
Preferences for Immunotherapy in Melanoma: A Systematic Review
Ann Livingstone et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Neeta Pandit-Taskar et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Revisiting Immunotherapy: A Focus on Prostate Cancer
Ha-Ram Cha et al.
CANCER RESEARCH (2020)
Imaging Responses to Immunotherapy with Novel PET Tracers
Anna-Larissa Niemeijer et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Frontline immunotherapy for NSCLC - the tale of the tail
Anne C. Chiang et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Principles of Immunotherapy in Melanoma
Adedayo A. Onitilo et al.
SURGICAL CLINICS OF NORTH AMERICA (2020)
Immunotherapy in Renal Cell Carcinoma: The Future Is Now
Antoine Deleuze et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Immunotherapy of multiple myeloma
Simone A. Minnie et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Immune escape and immunotherapy of acute myeloid leukemia
Luca Vago et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Novel Nuclear Medicine Imaging Applications in Immuno-Oncology
Stefano Frega et al.
CANCERS (2020)
What is the future of immunotherapy in multiple myeloma?
Leo Rasche et al.
BLOOD (2020)
Immunotherapy for pancreatic cancer: A 2020 update
Dimitrios Schizas et al.
CANCER TREATMENT REVIEWS (2020)
Biomarkers in immunotherapy: literature review and future directions
Rebecca Pharaon et al.
JOURNAL OF THORACIC DISEASE (2020)
Application and Prospects of Molecular Imaging in Immunotherapy
Weiqing Wang et al.
CANCER MANAGEMENT AND RESEARCH (2020)
89Zr-pembrolizumab biodistribution is influenced by PD-1-mediated uptake in lymphoid organs
Elly L. van der Veen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Molecular imaging in immuno-oncology: current status and translational perspectives
Luca Filippi et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2020)
Cell Tracking in Cancer Immunotherapy
Justine Perrin et al.
FRONTIERS IN MEDICINE (2020)
Monitoring of patients with metastatic melanoma treated with immune checkpoint inhibitors using PET-CT
Antonia Dirnitrakopoulou-Strauss
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes
Deborah B. Doroshow et al.
CLINICAL CANCER RESEARCH (2019)
Early Phase I Study of a 99mTc-Labeled Anti-Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non-Small Cell Lung Cancer
Yan Xing et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?
Yuxin Liu et al.
BLOOD REVIEWS (2019)
Advances in molecular imaging of immune checkpoint targets in malignancies: current and future prospect
Yang Du et al.
EUROPEAN RADIOLOGY (2019)
Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities
Vinod P. Balachandran et al.
GASTROENTEROLOGY (2019)
Tracers for non-invasive radionuclide imaging of immune checkpoint expression in cancer
Peter Wierstra et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2019)
Small molecules as theranostic agents in cancer immunology
Jindian Li et al.
THERANOSTICS (2019)
The yin and yang of imaging tumor associated macrophages with PET and MRI
Sudip Mukherjee et al.
THERANOSTICS (2019)
Small Molecules Drive Big Improvements in Immuno-Oncology Therapies
Bayard R. Huck et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial
Anne Katrin Berger et al.
BRITISH JOURNAL OF CANCER (2018)
The Immunoimaging Toolbox
Aaron T. Mayer et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Zr-89-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
Frederike Bensch et al.
NATURE MEDICINE (2018)
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer
A. N. Niemeijer et al.
NATURE COMMUNICATIONS (2018)
Prostate cancer immunotherapy: where are we and where are we going?
Marco A. De Velasco et al.
CURRENT OPINION IN UROLOGY (2018)
Imaging biomarker roadmap for cancer studies
James P. B. O'Connor et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant
John A. Ronald et al.
CANCER RESEARCH (2017)
Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies
Mathew Clement et al.
SCIENTIFIC REPORTS (2016)
PET-based molecular imaging in personalized oncology: potential of the assessment of therapeutic outcome
Antonia Dimitrakopoulou-Strauss
FUTURE ONCOLOGY (2015)
Big opportunities for small molecules in immuno-oncology
Jerry L. Adams et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
In vivo and in vitro evidence that 99mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery
Andor W. J. M. Glaudemans et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
Jonathan E. Rosenberg et al.
INVESTIGATIONAL NEW DRUGS (2014)
Maximizing the commercial value of personalized therapeutics and companion diagnostics
Cynthia H. Zhang et al.
NATURE BIOTECHNOLOGY (2013)
Share Paper
